What does the future hold for oral chemotherapeutic agents? Will they one day replace infusion therapies? Could they even transform cancer into a chronic, manageable disease treatable at home? Host Dr. Charles Turck speaks with Dr. Susan Goodin, Director of the Division of Pharmaceutical Sciences at The Cancer Institute of New Jersey, about the remarkable progress in research and development for oral chemotherapeutics.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
The Future of Oral Chemotherapeutic Agents
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
What does the future hold for oral chemotherapeutic agents? Will they one day replace infusion therapies? Could they even transform cancer into a chronic, manageable disease treatable at home? Host Dr. Charles Turck speaks with Dr. Susan Goodin, Director of the Division of Pharmaceutical Sciences at The Cancer Institute of New Jersey, about the remarkable progress in research and development for oral chemotherapeutics.
Facebook Comments